Ian Read

Catalyst, Inc. provides research and advisory services. The company was founded in 1962 and is headquartered in New York City, NY.

Saama Technologies, Inc. engages in the provision of consulting and systems integration services. It offers study conduct, study planning, and real world and commercial insight solutions The company was founded by Suresh Katta in 1997 and is headquartered in Campbell, CA.

The Partnership for New York City operates as a charitable organization. It is a network of business leaders and corporations working for the economic and cultural betterment of all five boroughs of the city. The firm provides networking opportunities, conducts research, participates in policy making and lobbies government. The company was founded by David Rockefeller in 2002 and is headquartered in New York, NY.

Pharmaceutical Research & Manufacturers of America provides pharmaceutical research and biotechnology services. It represents the country’s biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. The company was founded in 1958 and is headquartered Washington, DC.

Healthcare Leadership Council operates as a organization focusing on the provision of a healthcare system. The company is headquartered in Washington, DC.

The Council on Competitiveness is a nonpartisan organization that has been advocating for a competitiveness agenda for over three decades. The non-profit company is based in Washington. The organization aims to attract investment and talent, spur the commercialization of new ideas, and enhance productivity to raise the standard of living for all Americans. The council's members include CEOs, university presidents, labor leaders, and national lab directors who provide real-world perspective to policymakers. The council believes that with the right policies, the strengths and potential of the economy far outweigh the current challenges the nation faces on the path to higher growth and greater opportunity for all Americans. Deborah L. Wince-Smith has been the CEO of the American company since 1993.

The US-China Business Council is an organization that provides information, advisory, advocacy, and program services to its members. The non-profit company is based in Washington. The American company focuses on shaping the relationship between the United States and China. USCBC offers research and analyses on Chinese government personnel, member newsletters, and advisory services to answer sector-specific and general investment questions.

The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium.

Kennedy Center Corporate Fund operates as a nationwide partnership of distinguished business leaders who help to mobilize corporate partners and secure critical funding. The company was founded by Harold Burson in 1977 and is headquartered in Washington, DC.

Part of Pfizer Inc., Pfizer Pharmaceuticals, Inc. is an American company that manufactures pharmaceutical products.

Part of Pfizer Inc., Pfizer SA de CV develops and markets drugs.

TriNetX, Inc. provides an online data network for collaborative research. It enables hospitals, academic medical centers, physician networks, practices, and pharmaceuticals to participate in collaborative research and a public and private sustainability model for research informatics. The company was founded by Bard Geesaman in 2013 and is headquartered in Cambridge, MA.

avateramedical NV functions as an investment holding company. The firm operates its business through its subsidiary company: avateramedical GmbH. The company was founded by Hubertus von Grünberg and Jens-Uwe Stolzenburg and is headquartered in Amsterdam, Netherlands.

Population Health Investment Co., Inc. operates as a blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase and reorganization or similar business combination with one or more businesses. It intends to focus on companies in the healthcare industry such as the therapeutics sector. The company was founded by Clive A. Meanwell and Ian C. Read on September 11, 2020 and is headquartered in New York, NY.

Areteia Therapeutics, Inc. is a clinical stage biotechnology company that focuses on developing and delivering novel inflammation and immunology therapies for respiratory patients. The company is based in Short Hills, NJ, and the CEO of the company is Jorge Bartolome. The company's initial focus is on developing the first potential oral drug for eosinophilic asthma, with its lead drug candidate being dexpramipexole, a first-in-class oral eosinophil maturation inhibitor. Areteia was created by Population Health Partners and Knopp Biosciences, and a syndicate of leading life sciences and strategic investors has committed to investing up to $350 million in series A financing to establish Areteia and advance dexpramipexole through phase III clinical trials.